🇺🇸 NIMBEX in United States

575 US adverse-event reports

Safety signals — FAERS

Adverse reaction reports describe suspected side effects. A report does not mean the drug caused the event — co-medications, underlying disease and coincidence all contribute.

Most-reported reactions

  1. Hypotension — 106 reports (18.43%)
  2. Anaphylactic Shock — 92 reports (16%)
  3. Anaphylactic Reaction — 56 reports (9.74%)
  4. Renal Failure — 55 reports (9.57%)
  5. Cardiac Arrest — 51 reports (8.87%)
  6. Drug Ineffective — 50 reports (8.7%)
  7. Toxic Epidermal Necrolysis — 50 reports (8.7%)
  8. Erythema — 40 reports (6.96%)
  9. Anxiety — 38 reports (6.61%)
  10. Bronchospasm — 37 reports (6.43%)

Source database →

Other Anesthesia approved in United States

Frequently asked questions

Is NIMBEX approved in United States?

NIMBEX does not currently have US marketing authorisation in our dataset.

Who is the marketing authorisation holder for NIMBEX in United States?

Assistance Publique Hopitaux De Marseille is the originator. The local marketing authorisation holder may differ — check the official source linked above.